XBOM
HSIL
Market cap34mUSD
Nov 12, Last price
296.00INR
Name
H S India Ltd
Chart & Performance
P/E
39.03
P/S
2.94
EPS
7.58
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
13.65%
Revenues
1.07b
+0.97%
Net income
80m
-17.95%
CFO
88m
P
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hemant Surgical Industries Ltd. operates as a pharmaceutical company. It engages in the importing, manufacturing & marketing surgical and pharmaceutical products. The company was founded by Hanskumar Shamji Shah in 1985 and is headquartered in Mumbai, India.
Valuation
Title INR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||